Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) Consolidated Net Income (2024 - 2025)

RenovoRx's Consolidated Net Income history spans 2 years, with the latest figure at -$3.4 million for Q4 2025.

  • On a quarterly basis, Consolidated Net Income fell 35.34% to -$3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$12.1 million, a 14.14% decrease, with the full-year FY2025 number at -$12.1 million, down 14.14% from a year prior.
  • Consolidated Net Income hit -$3.4 million in Q4 2025 for RenovoRx, down from -$3.1 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for RNXT hit a ceiling of -$2.4 million in Q1 2024 and a floor of -$3.4 million in Q4 2025.